Finance

Lists
UNICHEMLAB:NSE
Unichem Laboratories Ltd
₹529.00
-9.88%
(-58.00) 1D
Jul 22, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for UNICHEMLAB...
Open
₹586.95
High
₹586.95
Low
₹528.30
Mkt. cap
37.23B
Avg. vol.
1.69M
Volume
314.22K
P/E ratio
14.76
52-wk high
₹687.20
52-wk low
₹278.20
EPS
₹35.85
Shares outstanding
70.38M
No. of employees
3K
Open
₹586.95
High
₹586.95
Low
₹528.30
Mkt. cap
37.23B
Avg. vol.
1.69M
Volume
314.22K
P/E ratio
14.76
52-wk high
₹687.20
52-wk low
₹278.20
EPS
₹35.85
Shares outstanding
70.38M
No. of employees
3K
News stories
From sources across the web
Profile
Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe. Wikipedia
About Unichem Laboratories Ltd
CEO-
Employees2.78K
Founded1944
HeadquartersMumbai, Maharashtra, India
SectorPharmaceutical industry
Websiteunichemlabs.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.27B
5.79B
5.21B
5.75B
Cost of goods sold
2.45B
2.70B
2.37B
3.41B
Cost of revenue
2.45B
2.70B
2.37B
3.41B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.07B
1.00B
992.70M
1.05B
Operating expense
2.91B
2.74B
2.71B
2.10B
Total operating expenses
5.36B
5.44B
5.08B
5.50B
Operating income
-93.00M
347.10M
135.30M
246.30M
Other non operating income
53.40M
209.70M
118.00M
-389.10M
EBT including unusual items
-90.20M
-108.20M
2.93B
187.90M
EBT excluding unusual items
-105.00M
474.40M
179.10M
271.70M
Income tax expense
14.50M
10.70M
291.40M
78.80M
Effective tax rate
-16.08%
-9.89%
9.93%
41.94%
Other operating expenses
1.52B
1.42B
1.40B
743.50M
Net income
-104.70M
-118.90M
2.64B
109.10M
Net profit margin
-1.99%
-2.05%
50.71%
1.90%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
53.00M
Interest expense
-65.40M
-82.40M
-74.20M
-92.80M
Net interest expenses
-65.40M
-82.40M
-74.20M
-39.80M
Depreciation and amortization charges
317.90M
314.70M
312.50M
306.10M
EBITDA
200.42M
663.40M
428.72M
541.10M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer